Patent details

EP1595146 Title: SCREENING ASSAYS FOR CANNABINOID-LIGAND-TYPE MODULATORS OF GPR55

Basic Information

Publication number:
EP1595146
PCT Application Number:
PCT/GB/2004/000571
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP047109228
PCT Publication Number:
WO/2004/074844
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
SCREENING ASSAYS FOR CANNABINOID-LIGAND-TYPE MODULATORS OF GPR55
French Title of Invention:
DOSAGES DE CRIBLAGE POUR MODULATEURS DE TYPE LIGANDS CANNABINOIDES DE GPR55
German Title of Invention:
SCREENING-TESTS FÜR CANNABINOID-LIGAND-ARTIGE MODULATOREN VON GPR55
SPC Number:

Dates

Filing date:
13/02/2004
Grant date:
23/04/2008
EP Publication Date:
23/04/2008
PCT Publication Date:
02/09/2004
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
16/11/2005
EP B1 Publication Date:
23/04/2008
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/02/2009
Expiration date:
13/02/2024
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/02/2004
 
 

Name:
AstraZeneca AB
Address:
-, 151 85 Södertälje, Sweden (SE)

Inventor

1

Name:
DRMOTA Tomas
Address:
Sweden (SE)

2

Name:
GREASLEY Peter
Address:
Sweden (SE)

3

Name:
GROBLEWSKI Thierry, Astrazeneca R & D Montreal
Address:
Canada (CA)

Priority

Priority Number:
448665 P
Priority Date:
18/02/2003
Priority Country:
United States (US)

Classification

Main IPC Class:
G01N 33/94;
Filing date Document type Number of pages